TGFB1 and non-small cell lung carcinoma: To evaluate the effect of cilengitide (Figure 4A and Supplementary Figure S1–S3) on TGF-β1-induced EMT in the presence of gefitinib, we conducted cell viability assays in NSCLC A549 cells, normal fibroblast IMR90 and normal epithelial CPAE cells.